corpus.blog
41554 blogs · [ { "id": "01a0c505-0227-7331-ab90-463f798251a3", "title": "OPT101 Starts a Phase-II Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/09/opt101-starts-phase-ii-clinical-trial.html", "published_at": "2026-09-18T00:48:24+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e12b10817", "title": "Allogeneic CD7-Targeted CAR-T Cell (RD13-02) Starts Second Phase-I Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/07/allogeneic-cd7-targeted-car-t-cell-rd13.html", "published_at": "2026-07-04T22:49:57+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e12b72a03", "title": "SAB-142 From SAb Biotherapeutics Starts a Phase II Trial (SAFEGUARD)", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/06/sab-142-from-sab-biotherapeutics-starts.html", "published_at": "2026-06-16T23:56:13+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e12cbe02f", "title": "Rezpegaldesleukin (or NKTR-358) Starts A Phase-IIΔ Clinical Trial on Honeymooners (RESET T1D)", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/06/a-new-clinical-trial-is-testing.html", "published_at": "2026-06-04T22:22:03+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e137a5689", "title": "Phase-I Clinical Trial of Islet Transplantation Into Eye", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/05/phase-i-clinical-trial-of-islet.html", "published_at": "2026-05-14T16:44:37+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e137fa0bd", "title": "Anti-Thymocyte Globulin and Verapamil Start A Phase-2 Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/04/anti-thymocyte-globulin-and-verapamil.html", "published_at": "2026-05-01T03:59:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e13dd67f6", "title": "GentiBio starts a Phase-I Clinical Trial on GNTI-122 in Honeymooners (POLARIS)", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/04/gentibio-starts-phase-i-clinical-trial.html", "published_at": "2026-04-09T00:44:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e1448de36", "title": "Results From An Omega-3 and Vitamin D Clinical Trial In People With Long Standing T1D", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/02/results-from-omega-3-and-vitamin-d.html", "published_at": "2026-02-24T05:55:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e1506c877", "title": "Open Letter: Focus On Hidden Transplanted Beta Cells", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/02/open-letter-focus-on-hidden.html", "published_at": "2026-02-07T00:57:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e155c40bd", "title": "SAR442970/Brivekimig Starts a Phase IIΔ Trial In Honeymooners (T1D OBTAIN)", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/01/sar442970brivekimig-starts-phase-ii.html", "published_at": "2026-01-30T22:55:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e16054e3b", "title": "Rituximab and Treg Cells Starts a Phase IIΔ Trial In Youth At Risk Of Diabetes", "url": "https://cureresearch4type1diabetes.blogspot.com/2026/01/rituximab-and-treg-cells-starts-phase.html", "published_at": "2026-01-07T19:37:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e16105695", "title": "Fecal Transplantation Starts A Phase-II Trial (FACT-T1D)", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/12/fecal-transplantation-starts-phase-ii.html", "published_at": "2025-12-18T04:01:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e16a30b34", "title": "CNK-UT009 Cell Therapy Starts A Phase-I Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/12/cnk-ut009-cell-therapy-starts-phase-i.html", "published_at": "2025-12-05T18:00:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e176333ce", "title": "IMMUNOSTEM starts a Phase-I Clinical Trial in Honeymooners", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/10/immunostem-starts-phase-i-clinical.html", "published_at": "2025-10-30T03:41:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e182c9d0a", "title": "Results from a Phase-II Clinical Trial of Baricitinib", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/09/results-from-phase-ii-clinical-trial-of.html", "published_at": "2025-09-27T14:53:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e18cf5073", "title": "Avotres Announces Results from a Phase-I Trial of AVT001", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/09/avotres-announces-results-from-phase-i.html", "published_at": "2025-09-06T15:33:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e192c5bfc", "title": "No Blog Postings Until August", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/06/no-blog-postings-until-august.html", "published_at": "2025-06-22T19:18:00+00:00" }, { "id": "01a08765-a0ef-71e2-8b01-5b8e19efe15c", "title": "Diamyd’s GABA-Based Remygen® Unsuccessful in Phase 1 Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/05/diamyds-gaba-based-remygen-unsuccessful.html", "published_at": "2025-05-16T15:26:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa8e891939", "title": "Changes to My Blogging: AI", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/05/changes-to-my-blogging-ai.html", "published_at": "2025-05-09T03:12:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa8f304f52", "title": "Sana Biotechnology Reports First Results For Islet Transplants Without Immunosuppression", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/04/sana-biotechnology-reports-first.html", "published_at": "2025-04-25T04:24:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa8feccdf3", "title": "TIXIMED Starts a Phase 1 Study of TIX100", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/03/tiximed-starts-phase-1-study-of-tix100.html", "published_at": "2025-03-18T17:25:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa90a6ba53", "title": "Combination of Harmine and GLP-1RA Completes Phase-I Clinical Trial (In Healthy People)", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/03/combination-of-harmine-and-glp-1ra.html", "published_at": "2025-03-07T23:03:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa90edb81e", "title": "Denosumab Starts A Phase-I Trial In People With Established T1D", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/01/denosumab-starts-phase-i-trial-in.html", "published_at": "2025-01-31T22:20:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa91ab1cd4", "title": "What To Watch In 2025", "url": "https://cureresearch4type1diabetes.blogspot.com/2025/01/what-to-watch-in-2025.html", "published_at": "2025-01-19T23:28:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa922f1b76", "title": "Breakthrough T1D (formerly JDRF) Funding for a Cure 2024", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/12/jdrf-funding-for-cure-2024.html", "published_at": "2025-01-01T02:10:00+00:00" }, { "id": "01a08765-a0f0-71b2-8b2e-b4fa92c5f139", "title": "Fenofibrate Is Unsuccessful In A Phase-IIΔ Trial In Honeymooners", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/12/fenofibrate-is-unsuccessful-in-phase-ii.html", "published_at": "2024-12-24T04:51:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd50c9727", "title": "Encellin Starts a Phase-I Trial of ENC-201-CED (Encapsulated Beta Cells)", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/11/encellin-starts-phase-i-trial-of-enc.html", "published_at": "2024-11-20T04:09:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd5f56a7a", "title": "Frexalimab Starts A Phase-IIΔ Clinical Trial (FABULINUS)", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/11/frexalimab-starts-phase-ii-clinical.html", "published_at": "2024-11-08T15:47:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd60467c1", "title": "The full story on \"Stem cells reverse woman’s diabetes — a world first\"", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/10/the-full-story-on-stem-cells-reverse.html", "published_at": "2024-10-06T15:42:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd60e6300", "title": "Combo of Rituximab and Abatacept Starts a Phase-II In Honeymooners (T1D RELAY)", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/08/combo-of-rituximab-and-abatacept-starts.html", "published_at": "2024-08-18T23:19:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd6ad567d", "title": "Abrocitinib and Ritlecitinib Start A Phase-IIΔ Clinical Trail in Honeymooners (JAKPOT)", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/07/abrocitinib-and-ritlecitinib-start.html", "published_at": "2024-07-17T03:57:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd7ad406c", "title": "BMF-219 Starts a Phase-IIΔ", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/06/bmf-219-starts-phase-ii.html", "published_at": "2024-06-05T03:20:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd8511c10", "title": "Fenofibrate Starts A Phase-IIΔ Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/05/fenofibrate-starts-phase-ii-trial.html", "published_at": "2024-05-02T03:43:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd8e8bcc1", "title": "Siplizumab Starts Two Trials in Honeymoon T1D (DESIGNATE and STRIDE)", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/04/siplizumab-starts-two-trials-in.html", "published_at": "2024-04-26T17:15:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cd9753002", "title": "Why I Don't Blog On How To Vote For T1D (part 1)", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/04/why-i-dont-blog-on-how-to-vote-for-t1d.html", "published_at": "2024-04-13T02:52:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cda46b665", "title": "Diamyd Update Part 2: JDRF Flexibilty In Funding and Diamyd In More People", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/03/diamyd-update-part-2-jdrf-flexibilty-in.html", "published_at": "2024-03-22T16:14:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cdad2520d", "title": "Levicure's Combination Therapy", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/03/levicures-combination-therapy.html", "published_at": "2024-03-08T18:12:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cdb14e0da", "title": "Results from a Phase-IIΔ Trial of Pleconaril and Ribavirin", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/01/results-from-phase-ii-trial-of.html", "published_at": "2024-01-30T05:06:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cdba4f24d", "title": "Results From A Phase-IIΔ Baricitinib (Olumiant)", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/01/results-from-phase-ii-baricitinib.html", "published_at": "2024-01-22T18:07:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cdc0b29aa", "title": "What To Watch In 2024", "url": "https://cureresearch4type1diabetes.blogspot.com/2024/01/what-to-watch-in-2024.html", "published_at": "2024-01-06T17:56:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cdd007322", "title": "Diamyd Update", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/12/diamyd-update.html", "published_at": "2023-12-24T23:40:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cddbd0d92", "title": "Islet Cell Transplantation Clinical Trails", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/12/islet-cell-transplantation-clinical.html", "published_at": "2023-12-16T19:26:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cde771f3b", "title": "Teplizumab/Tzield Reports Results From A Phase-III in Honeymooners (PROTECT)", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/11/teplizumabtzield-reports-results-from.html", "published_at": "2023-11-29T04:57:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cde9b376b", "title": "JDRF Funding for a Cure 2023", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/11/jdrf-funding-for-cure-2023.html", "published_at": "2023-11-11T22:09:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87cdf6224c1", "title": "DFMO Starts A Phase-II Clinical Trial (TADPOL)", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/10/dfmo-starts-phase-ii-clinical-trial.html", "published_at": "2023-10-10T02:49:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87ce038bb90", "title": "Strong Results from a Pilot Study of Semaglutide in Adult Honeymooners", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/09/strong-results-from-pilot-study-of.html", "published_at": "2023-09-21T04:39:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87ce10361e7", "title": "T1D Research News (Quick Bits for July)", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/07/t1d-research-news-quick-bits-for-july.html", "published_at": "2023-07-31T17:49:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87ce1f463ef", "title": "CELZ-201 Starts a Phase-I Trial (CREATE-1)", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/06/celz-201-starts-phase-i-trial-create-1.html", "published_at": "2023-06-13T02:45:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87ce23c749a", "title": "Dompé Starts GLADIATOR, a Phase-III Clinical Trial of Ladarixin", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/05/dompe-starts-gladiator-phase-iii.html", "published_at": "2023-05-10T03:17:00+00:00" }, { "id": "01a0c516-be64-7036-801d-f87ce26e5e8e", "title": "T1D Research News (Quick Bits from April)", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/04/t1d-research-news-quick-bits-from-april.html", "published_at": "2023-04-07T16:55:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52aebea3b7c", "title": "Results from a Phase-II Verapamil Study", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/03/results-from-phase-ii-verapamil-study.html", "published_at": "2023-04-01T03:35:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52aecb9231c", "title": "Influenza Vaccination Starts a Phase-II? Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/03/influenza-vaccination-starts-phase-ii.html", "published_at": "2023-03-20T20:48:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52aed9ab3dd", "title": "Ixekizumab (Taltz) Starts a Phase-II? Trial In Honeymooners", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/02/ixekizumab-taltz-starts-phase-ii-trial.html", "published_at": "2023-02-27T21:12:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52aedf4da30", "title": "OPT101 Starts A Phase-I Trial in Adults with Established T1D", "url": "https://cureresearch4type1diabetes.blogspot.com/2023/02/opt101-starts-phase-i-trial-in-adults.html", "published_at": "2023-02-10T02:18:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52aee1a5fda", "title": "Youtube Video Describing How JDRF Makes Funding Decisions", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/12/youtube-video-describing-how-jdrf-makes.html", "published_at": "2022-12-26T23:43:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52aef002417", "title": "ADSCC Starts Phase-I Clinical Trial of Extracorporeal Photopheresis (Opera)", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/12/asdcc-starts-phase-i-clinical-trial-of.html", "published_at": "2022-12-16T06:14:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52aef62f206", "title": "The FDA Approves Teplizumab Under The Name TZIELD™ (teplizumab-mzwv)", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/12/the-fda-approves-teplizumab-under-name.html", "published_at": "2022-12-03T19:11:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af01e7115", "title": "Results from MultiPepT1De (Multi Peptide Vaccine) by Powrie at King’s College London", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/11/results-from-multipept1de-multi-peptide.html", "published_at": "2022-11-17T03:35:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af09e1caf", "title": "JDRF Funding for a Cure 2022", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/10/jdrf-funding-for-cure-2022.html", "published_at": "2022-10-17T01:20:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af1397f6e", "title": "Research Dropped As A Practical Cure", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/09/research-dropped-as-practical-cure.html", "published_at": "2022-09-17T02:42:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af21d9d2d", "title": "Provention Bio Update", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/07/provention-bio-update.html", "published_at": "2022-07-11T17:37:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af2c87805", "title": "NN1845 (a glucose sensitive insulin) Starts A Second Phase-1 Clinical Trail", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/05/nn1845-glucose-sensitive-insulin-starts.html", "published_at": "2022-05-05T03:29:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af3b11445", "title": "ViaCyte and CRISPR start a Phase-I Clinical Trial (VCTX210A-101)", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/04/viacyte-and-crispr-start-phase-i.html", "published_at": "2022-04-06T03:30:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af3cd71c1", "title": "Update On Teplizumab from Provention Bio", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/03/update-on-teplizumab-from-provention-bio.html", "published_at": "2022-03-22T03:37:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af3f8981f", "title": "Verapamil Starts A Phase-II Trial (Ver-A-T1D)", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/02/verapamil-sr-starts-phase-ii-trial-ver.html", "published_at": "2022-02-17T01:52:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af4f030f2", "title": "No One Was Cured Of Type-1 Diabetes in 2021", "url": "https://cureresearch4type1diabetes.blogspot.com/2022/01/no-one-was-cured-of-type-1-diabetes-in.html", "published_at": "2022-01-13T05:05:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af564acb3", "title": "Possible Cures for Type-1 in the News (August)", "url": "https://cureresearch4type1diabetes.blogspot.com/2021/08/possible-cures-for-type-1-in-news-august.html", "published_at": "2021-08-31T03:35:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af59c5b2d", "title": "TrialNet In General", "url": "https://cureresearch4type1diabetes.blogspot.com/2021/07/trialnet-in-general.html", "published_at": "2021-07-18T03:26:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af6731f17", "title": "Novo Nordisk and TrialNet Start TOPPLE T1D: Phase-I Trial of Four Protein Plasmid", "url": "https://cureresearch4type1diabetes.blogspot.com/2021/04/novo-nordisk-and-trialnet-start-topple.html", "published_at": "2021-04-05T03:55:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af75cfb54", "title": "Possible Cures for Type-1 in the News (March)", "url": "https://cureresearch4type1diabetes.blogspot.com/2021/03/possible-cures-for-type-1-in-news-march.html", "published_at": "2021-03-27T17:31:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af81a2208", "title": "Ruxolitinib Case Study", "url": "https://cureresearch4type1diabetes.blogspot.com/2021/02/ruxolitinib-case-study.html", "published_at": "2021-02-22T01:08:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af8acda96", "title": "PIpepTolDC Starts A Phase-I Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2021/01/pipeptoldc-starts-phase-i-clinical-trial.html", "published_at": "2021-01-18T01:54:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af8b564bf", "title": "Possible Cures for Type-1 in the News (January)", "url": "https://cureresearch4type1diabetes.blogspot.com/2021/01/possible-cures-for-type-1-in-news.html", "published_at": "2021-01-09T21:21:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af8b921ce", "title": "Results from a Faecal Microbiota Transplantation Phase-I Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/12/results-from-faecal-microbiota.html", "published_at": "2020-12-27T23:08:00+00:00" }, { "id": "01a0c521-9c42-7037-b699-c52af967fdc7", "title": "Glucose-Sensitive Insulin (NN1845) Starts A Phase-I Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/12/glucose-sensitive-insulin-nn1845-starts.html", "published_at": "2020-12-12T22:47:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1219c6e8", "title": "Diversity, Inclusion and Equality (In T1D Research)", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/11/diversity-inclusion-and-equality-in-t1d.html", "published_at": "2020-11-17T04:11:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def12b6b4ba", "title": "JDRF Funding for a Cure 2020", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/10/jdrf-funding-for-cure-2020.html", "published_at": "2020-10-25T03:14:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def13a0a505", "title": "Iscalimab (CFZ533) Starts a Phase-II? Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/10/iscalimab-cfz533-starts-phase-ii.html", "published_at": "2020-10-03T18:52:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1410f574", "title": "Update On Teplizumab", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/08/update-on-teplizumab.html", "published_at": "2020-08-15T19:09:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def145f4c5f", "title": "Two New Clinical Trials (HCQ and Baby Teeth Stem Cells)", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/08/two-new-clinical-trials-hcq-and-baby.html", "published_at": "2020-08-04T01:10:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1539fc5b", "title": "News from ADA 2020", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/07/news-from-ada-2020.html", "published_at": "2020-07-03T19:36:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def155e2b5f", "title": "Possible Cures for Type-1 in the News (June)", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/05/possible-cures-for-type-1-in-news-june.html", "published_at": "2020-06-13T19:55:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def161cd2ca", "title": "Strong Results from a Single Case use of Fenofibrate and Start Of A Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/06/strong-results-from-single-case-use-of.html", "published_at": "2020-06-03T05:07:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1715769f", "title": "Possible Cures for Type-1 in the News (May)", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/05/possible-cures-for-type-1-in-news-may.html", "published_at": "2020-05-12T03:14:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def178be28e", "title": "Possible Cures for Type-1 in the News (April)", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/04/possible-cures-for-type-1-in-news-april.html", "published_at": "2020-04-04T16:45:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def187beff7", "title": "Results From a Phase-I Clinical Trial of IMCY-0098", "url": "https://cureresearch4type1diabetes.blogspot.com/2020/03/results-from-phase-i-clinical-trial-of.html", "published_at": "2020-03-10T03:34:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1928b50a", "title": "Clinical Trials Using Probiotics For Type-1 Diabetes", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/12/clinical-trials-using-probiotics-for.html", "published_at": "2019-12-23T07:11:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def195a1532", "title": "Avotres's AVT001 Starts A Phase-I Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/12/avotress-avt001-starts-phase-i-trial.html", "published_at": "2019-12-03T21:29:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1a4a3f4b", "title": "Combo of AG019 and Teplizumab Starts A Phase-I Trial In Honeymooners", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/11/combo-of-ag019-and-teplizumab-starts.html", "published_at": "2019-11-23T16:01:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1aadf439", "title": "Is there any association between gut microbiota and type 1 diabetes?", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/11/is-there-any-association-between-gut.html", "published_at": "2019-11-16T04:25:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1b70d40b", "title": "TOL-3021 Starts A Phase-II Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/10/tol-3021-starts-phase-ii-clinical-trial.html", "published_at": "2019-10-19T20:18:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1c54455f", "title": "JDRF Funding for a Cure 2019", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/10/jdrf-funding-for-cure-2019.html", "published_at": "2019-10-12T00:01:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1d3741ac", "title": "Possible Cures for Type-1 in the News (September)", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/09/possible-cures-for-type-1-in-news.html", "published_at": "2019-09-29T00:34:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1db7c2e1", "title": "Teplizumab Phase-II Results For Prevention And Starts A Phase-III On Honeymooners", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/09/teplizumab-phase-ii-results-for.html", "published_at": "2019-09-20T03:50:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1e7b8897", "title": "Personal Note", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/08/personal-note.html", "published_at": "2019-08-08T16:17:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1eeb1619", "title": "MER3101 Starts a Phase-I Clinical Trial", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/06/mer3101-starts-phase-i-clinical-trial.html", "published_at": "2019-06-19T04:27:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1f3b66c3", "title": "Possible Cures for Type-1 in the News (May)", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/05/possible-cures-for-type-1-in-news-may.html", "published_at": "2019-05-02T04:30:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def1ffd72d8", "title": "Can A Rotavirus Vaccine Prevent Type 1 Diabetes In Some People?", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/04/can-rotavirus-vaccine-prevent-type-1.html", "published_at": "2019-04-18T05:13:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def2061400a", "title": "My Theranos Story", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/03/my-theranos-story.html", "published_at": "2019-03-30T02:31:00+00:00" }, { "id": "01a0c52d-5221-70a9-8c32-2def2120a59d", "title": "Azithromycin Starts A Phase-II? Clinical Trial (AIDIT)", "url": "https://cureresearch4type1diabetes.blogspot.com/2019/03/azithromycin-starts-phase-ii-clinical.html", "published_at": "2019-03-23T17:37:00+00:00" } ] posts Claim your blog
Back to cureresearch4type1diabetes.blogspot.com
Blog · corpus.blog/blogs/cureresearch4type1diabetes.blogspot.com/posts

cureresearch4type1diabetes.blogspot.com

cureresearch4type1diabetes.blogspot.com

2026

OPT101 Starts a Phase-II Clinical Trialoriginal ↗
18 Sept 2026
Allogeneic CD7-Targeted CAR-T Cell (RD13-02) Starts Second Phase-I Clinical Trialoriginal ↗
4 Jul 2026
SAB-142 From SAb Biotherapeutics Starts a Phase II Trial (SAFEGUARD)original ↗
16 Jun 2026
Rezpegaldesleukin (or NKTR-358) Starts A Phase-IIΔ Clinical Trial on Honeymooners (RESET T1D)original ↗
4 Jun 2026
Phase-I Clinical Trial of Islet Transplantation Into Eyeoriginal ↗
14 May 2026
Anti-Thymocyte Globulin and Verapamil Start A Phase-2 Clinical Trialoriginal ↗
1 May 2026
GentiBio starts a Phase-I Clinical Trial on GNTI-122 in Honeymooners (POLARIS)original ↗
9 Apr 2026
Results From An Omega-3 and Vitamin D Clinical Trial In People With Long Standing T1Doriginal ↗
24 Feb 2026
Open Letter: Focus On Hidden Transplanted Beta Cellsoriginal ↗
7 Feb 2026
SAR442970/Brivekimig Starts a Phase IIΔ Trial In Honeymooners (T1D OBTAIN)original ↗
30 Jan 2026
Rituximab and Treg Cells Starts a Phase IIΔ Trial In Youth At Risk Of Diabetesoriginal ↗
7 Jan 2026

2025

Fecal Transplantation Starts A Phase-II Trial (FACT-T1D)original ↗
18 Dec 2025
CNK-UT009 Cell Therapy Starts A Phase-I Clinical Trialoriginal ↗
5 Dec 2025
IMMUNOSTEM starts a Phase-I Clinical Trial in Honeymoonersoriginal ↗
30 Oct 2025
Results from a Phase-II Clinical Trial of Baricitiniboriginal ↗
27 Sept 2025
Avotres Announces Results from a Phase-I Trial of AVT001original ↗
6 Sept 2025
No Blog Postings Until Augustoriginal ↗
22 Jun 2025
Diamyd’s GABA-Based Remygen® Unsuccessful in Phase 1 Clinical Trialoriginal ↗
16 May 2025
Changes to My Blogging: AIoriginal ↗
9 May 2025
Sana Biotechnology Reports First Results For Islet Transplants Without Immunosuppressionoriginal ↗
25 Apr 2025
TIXIMED Starts a Phase 1 Study of TIX100original ↗
18 Mar 2025
Combination of Harmine and GLP-1RA Completes Phase-I Clinical Trial (In Healthy People)original ↗
7 Mar 2025
Denosumab Starts A Phase-I Trial In People With Established T1Doriginal ↗
31 Jan 2025
What To Watch In 2025original ↗
19 Jan 2025
Breakthrough T1D (formerly JDRF) Funding for a Cure 2024original ↗
1 Jan 2025

2024

Fenofibrate Is Unsuccessful In A Phase-IIΔ Trial In Honeymoonersoriginal ↗
24 Dec 2024
Encellin Starts a Phase-I Trial of ENC-201-CED (Encapsulated Beta Cells)original ↗
20 Nov 2024
Frexalimab Starts A Phase-IIΔ Clinical Trial (FABULINUS)original ↗
8 Nov 2024
The full story on "Stem cells reverse woman’s diabetes — a world first"original ↗
6 Oct 2024
Combo of Rituximab and Abatacept Starts a Phase-II In Honeymooners (T1D RELAY)original ↗
18 Aug 2024
Abrocitinib and Ritlecitinib Start A Phase-IIΔ Clinical Trail in Honeymooners (JAKPOT)original ↗
17 Jul 2024
BMF-219 Starts a Phase-IIΔoriginal ↗
5 Jun 2024
Fenofibrate Starts A Phase-IIΔ Trialoriginal ↗
2 May 2024
Siplizumab Starts Two Trials in Honeymoon T1D (DESIGNATE and STRIDE)original ↗
26 Apr 2024
Why I Don't Blog On How To Vote For T1D (part 1)original ↗
13 Apr 2024
Diamyd Update Part 2: JDRF Flexibilty In Funding and Diamyd In More Peopleoriginal ↗
22 Mar 2024
Levicure's Combination Therapyoriginal ↗
8 Mar 2024
Results from a Phase-IIΔ Trial of Pleconaril and Ribavirinoriginal ↗
30 Jan 2024
Results From A Phase-IIΔ Baricitinib (Olumiant)original ↗
22 Jan 2024
What To Watch In 2024original ↗
6 Jan 2024

2023

Diamyd Updateoriginal ↗
24 Dec 2023
Islet Cell Transplantation Clinical Trailsoriginal ↗
16 Dec 2023
Teplizumab/Tzield Reports Results From A Phase-III in Honeymooners (PROTECT)original ↗
29 Nov 2023
JDRF Funding for a Cure 2023original ↗
11 Nov 2023
DFMO Starts A Phase-II Clinical Trial (TADPOL)original ↗
10 Oct 2023
Strong Results from a Pilot Study of Semaglutide in Adult Honeymoonersoriginal ↗
21 Sept 2023
T1D Research News (Quick Bits for July)original ↗
31 Jul 2023
CELZ-201 Starts a Phase-I Trial (CREATE-1)original ↗
13 Jun 2023
Dompé Starts GLADIATOR, a Phase-III Clinical Trial of Ladarixinoriginal ↗
10 May 2023
T1D Research News (Quick Bits from April)original ↗
7 Apr 2023
Results from a Phase-II Verapamil Studyoriginal ↗
1 Apr 2023
Influenza Vaccination Starts a Phase-II? Clinical Trialoriginal ↗
20 Mar 2023
Ixekizumab (Taltz) Starts a Phase-II? Trial In Honeymoonersoriginal ↗
27 Feb 2023
OPT101 Starts A Phase-I Trial in Adults with Established T1Doriginal ↗
10 Feb 2023

2022

Youtube Video Describing How JDRF Makes Funding Decisionsoriginal ↗
26 Dec 2022
ADSCC Starts Phase-I Clinical Trial of Extracorporeal Photopheresis (Opera)original ↗
16 Dec 2022
The FDA Approves Teplizumab Under The Name TZIELD™ (teplizumab-mzwv)original ↗
3 Dec 2022
Results from MultiPepT1De (Multi Peptide Vaccine) by Powrie at King’s College Londonoriginal ↗
17 Nov 2022
JDRF Funding for a Cure 2022original ↗
17 Oct 2022
Research Dropped As A Practical Cureoriginal ↗
17 Sept 2022
Provention Bio Updateoriginal ↗
11 Jul 2022
NN1845 (a glucose sensitive insulin) Starts A Second Phase-1 Clinical Trailoriginal ↗
5 May 2022
ViaCyte and CRISPR start a Phase-I Clinical Trial (VCTX210A-101)original ↗
6 Apr 2022
Update On Teplizumab from Provention Biooriginal ↗
22 Mar 2022
Verapamil Starts A Phase-II Trial (Ver-A-T1D)original ↗
17 Feb 2022
No One Was Cured Of Type-1 Diabetes in 2021original ↗
13 Jan 2022

2021

Possible Cures for Type-1 in the News (August)original ↗
31 Aug 2021
TrialNet In Generaloriginal ↗
18 Jul 2021
Novo Nordisk and TrialNet Start TOPPLE T1D: Phase-I Trial of Four Protein Plasmidoriginal ↗
5 Apr 2021
Possible Cures for Type-1 in the News (March)original ↗
27 Mar 2021
Ruxolitinib Case Studyoriginal ↗
22 Feb 2021
PIpepTolDC Starts A Phase-I Clinical Trialoriginal ↗
18 Jan 2021
Possible Cures for Type-1 in the News (January)original ↗
9 Jan 2021

2020

Results from a Faecal Microbiota Transplantation Phase-I Clinical Trialoriginal ↗
27 Dec 2020
Glucose-Sensitive Insulin (NN1845) Starts A Phase-I Clinical Trialoriginal ↗
12 Dec 2020
Diversity, Inclusion and Equality (In T1D Research)original ↗
17 Nov 2020
JDRF Funding for a Cure 2020original ↗
25 Oct 2020
Iscalimab (CFZ533) Starts a Phase-II? Clinical Trialoriginal ↗
3 Oct 2020
Update On Teplizumaboriginal ↗
15 Aug 2020
Two New Clinical Trials (HCQ and Baby Teeth Stem Cells)original ↗
4 Aug 2020
News from ADA 2020original ↗
3 Jul 2020
Possible Cures for Type-1 in the News (June)original ↗
13 Jun 2020
Strong Results from a Single Case use of Fenofibrate and Start Of A Clinical Trialoriginal ↗
3 Jun 2020
Possible Cures for Type-1 in the News (May)original ↗
12 May 2020
Possible Cures for Type-1 in the News (April)original ↗
4 Apr 2020
Results From a Phase-I Clinical Trial of IMCY-0098original ↗
10 Mar 2020

2019

Clinical Trials Using Probiotics For Type-1 Diabetesoriginal ↗
23 Dec 2019
Avotres's AVT001 Starts A Phase-I Trialoriginal ↗
3 Dec 2019
Combo of AG019 and Teplizumab Starts A Phase-I Trial In Honeymoonersoriginal ↗
23 Nov 2019
Is there any association between gut microbiota and type 1 diabetes?original ↗
16 Nov 2019
TOL-3021 Starts A Phase-II Clinical Trialoriginal ↗
19 Oct 2019
JDRF Funding for a Cure 2019original ↗
12 Oct 2019
Possible Cures for Type-1 in the News (September)original ↗
29 Sept 2019
Teplizumab Phase-II Results For Prevention And Starts A Phase-III On Honeymoonersoriginal ↗
20 Sept 2019
Personal Noteoriginal ↗
8 Aug 2019
MER3101 Starts a Phase-I Clinical Trialoriginal ↗
19 Jun 2019
Possible Cures for Type-1 in the News (May)original ↗
2 May 2019
Can A Rotavirus Vaccine Prevent Type 1 Diabetes In Some People?original ↗
18 Apr 2019
My Theranos Storyoriginal ↗
30 Mar 2019
Azithromycin Starts A Phase-II? Clinical Trial (AIDIT)original ↗
23 Mar 2019
Next